Advertisement

Lung Pathology pp 325-383 | Cite as

Miscellaneous Pulmonary Disease

Chapter
  • 1.8k Downloads
Part of the Current Clinical Pathology book series (CCPATH)

Abstract

In this chapter, a series of cases is presented that have provoked significant thought on the part of the consulting and consulted pathologists. Most of these cases don’t fall neatly into the context of other chapters in this volume. A number of these cases illustrate patterns of pulmonary disease that are not diagnostic and challenge the pathologist to offer an intelligent differential diagnosis. A brief discussion of some of these relevant diagnoses follows.

Keywords

Hypersensitivity Pneumonitis Open Biopsy Lung Pathology Congenital Cystic Adenomatoid Malformation Pseudoxanthoma Elasticum 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Suggested Readings Hypersensitivity Pneumonitis

  1. 1.
    Sumi Y, Nagura H, Takeuchi M. Granulomatous lesions in the lung induced by inhalation of mold spores. Virch Arch 1994;424:661–668.CrossRefGoogle Scholar
  2. 2.
    Coleman A, Colby TV. Histologic diagnosis of extrinsic allergic alveolitis. Am J Surg Pathol 1988;12:514–518.PubMedGoogle Scholar
  3. 3.
    Perry LP, Iwata M, Tazelaar HD, Colby TV, Yousem SA. Pulmonary mycotoxicosis: a clinicopathologic study of three cases. Mod Pathol 1998;11:432–436.PubMedGoogle Scholar

Amiodarone Pneumonitis

  1. 1.
    Jacobson W Stewart S, Gresham GA, Goddard MJ. Effect of amiodarone on the lung shown by polarized light microscopy. Arch Pathol Lab Med 1997;121:1269–1271.PubMedGoogle Scholar
  2. 2.
    Camus P, Lombard J-N, Perrichon M, et al. Bronchiolitis obliterans organising pneumonia in patients taking acebutolol or amiodarone. Thorax 1989;44:711–715.PubMedGoogle Scholar
  3. 3.
    Liu FL-W, Cohen RD, Downar E, Butany JW, Edelson JD, Rebuck AS. Amiodarone pulmonary toxicity: functional and ultrastructural evaluation. Thorax 1986;41:100–105.PubMedGoogle Scholar
  4. 4.
    Wilson BD, Lippmann ML. Pulmonary accumulation of amiodarone and N-desthylamiodarone. Relationship to the development of pulmonary toxicity. Am Rev Respir Dis 1990;141:1553–1558.PubMedGoogle Scholar
  5. 5.
    Dean PJ, Groshart KD, Porterfield JG, Iansmith DH, Golden EB Jr. Amiodarone-associated pulmonary toxicity. A clinical and pathologic study of eleven cases. Am J Clin Pathol 1987;87:7–13.PubMedGoogle Scholar
  6. 6.
    Myers JL, Kennedy JI, Plumb VJ. Amiodarone lung: pathologic findings in clinically toxic patients. Hum Pathol 1987;18:349–354.PubMedCrossRefGoogle Scholar

Hemorrhage

  1. 1.
    Mark EJ, Ramirez JF. Pulmonary capillaritis and hemorrhage in patients with systemic vasculitis. Arch Pathol Lab Med 1985;109:413–418.PubMedGoogle Scholar
  2. 2.
    Yoshikawa Y, Watanabe T. Pulmonary lesions in Wegener’s granulomatosis: a clinicopathologic study of 22 autopsy cases. Hum Pathol 1986;17:401–410.PubMedCrossRefGoogle Scholar
  3. 3.
    Myers JL, Katzenstein A-LA. Microangiitis in lupus-induced pulmonary hemorrhage. Am J Clin Pathol 1986;85:552–556.PubMedGoogle Scholar
  4. 4.
    Mark EJ, Matsubara O, Tan-Liu NS, Fienberg R. The pulmonary biopsy in the early diagnosis of Wegener’s (pathergic) granulomatosis: a study based on 35 open lung biopsies. Hum Pathol 1988;19:1065–1071.PubMedCrossRefGoogle Scholar
  5. 5.
    Travis WD, Colby TV, Lombard C, Carpenter HA. A clinicopathologic study of 34 cases of diffuse pulmonary hemorrhage with lung biopsy confirmation. Am J Surg Pathol 1990;14:1112–1125.PubMedGoogle Scholar
  6. 6.
    Yoshimura N, Matsubara O, Tamura A, Kasuga T, Mark EJ. Wegener’s granulomatosis. Associated with diffuse pulmonary hemorrhage. Acta Pathol Japonica 1992;42:657–661.Google Scholar

Other Pulmonary Diseases

  1. 1.
    Gough J. Differential diagnosis in the pathology of asbestosis. Ann NY Acad Sci 1965;132:368–372.PubMedCrossRefGoogle Scholar
  2. 2.
    Hourihane DO’B, McCaughey WTE. Pathological aspects of asbestosis. Postgrad Med J 1966;42:613–622.PubMedGoogle Scholar
  3. 3.
    Churg A, Warnock ML, Green N. Analysis of the cores of ferruginous (asbestos) bodies from the general population. II. True asbestos bodies and pseudoasbestos bodies. Lab Invest 1979;40:31–38.PubMedGoogle Scholar
  4. 4.
    Lerman Y, Ribak J, Selikoff IJ. Hazards of lung biopsy in asbestos workers. Br J Indust Med 1986;43:165–169.Google Scholar
  5. 5.
    Bellis D, Andrion A, Delsedime L, Mollo F. Minimal pathologic changes of the lung and asbestos exposure. Hum Pathol 1989;20:102–106.PubMedCrossRefGoogle Scholar
  6. 6.
    Roggli VL, Benning TL. Asbestos bodies in pulmonary hilar lymph nodes. Mod Pathol 1990;3:513–517.PubMedGoogle Scholar
  7. 7.
    Gaensler EA, Jederlinic PJ, Churg A. Idiopathic pulmonary fibrosis in asbestos-exposed workers. Am Rev Respir Dis 1991;144:689–696.PubMedGoogle Scholar
  8. 8.
    Hammar SP. Controversies and uncertainties concerning the pathologic features and pathologic diagnosis of asbestosis. Sem Diag Pathol 1992;9:102–109.Google Scholar
  9. 9.
    Travis WD, Colby TV, Koss MN, Rosado-de-Christenson ML, Müller NL, King TE Jr. Non-neoplastic disorders of the lower respiratory tract. Washington, DC. American Registry of Pathology and the Armed Forces Institute of Pathology, 2002;829.Google Scholar
  10. 10.
    Schroeder SA, Shannon DC, Mark EJ. Cellular interstitial pneumonitis in infants. A clinicopathological study. Chest 1992;101:1065–1069.PubMedGoogle Scholar
  11. 11.
    Moolman JA, Bardin PG, Rossouw DJ, Joubert JR. Cyclosporin as a treatment for interstitial lung disease of unknown aetiology. Thorax 1991;46:592–595.PubMedCrossRefGoogle Scholar
  12. 12.
    Nicholson AG, Kim H, Corrin B, Bush A, du Bois RM, Sheppard MN. The value of classifying interstitial pneumonitis in childhood according to defined histological patterns. Histopathology 1998;33:203–211.PubMedCrossRefGoogle Scholar
  13. 13.
    Katzenstein A-LA, Gordon LP, Oliphant M, Swender PT. Chronic pneumonitis of infancy. A unique form of interstitial lung disease occurring in early childhood. Am J Surg Pathol 1995;19:439–447.PubMedCrossRefGoogle Scholar
  14. 14.
    Fan LL, Langston C. Chronic interstitial lung disease in children. Ped Pulmonol 1993;16:184–196.CrossRefGoogle Scholar
  15. 15.
    Stocker JT. The respiratory tract. In: Pediatric Pathology, second edition, Stocker JT and Dehner LP, eds. Lippincott Williams and Wilkins, Philadelphia: 2001, pp. 445–518.Google Scholar
  16. 16.
    Brown M, Pysher T, Coffin CM. Lymphangioma and congenital pulmonary lymphangiectasis: a histologic, immunohistochemical, and clinicopathological comparison. Mod Pathol 1999;12:569–575.PubMedGoogle Scholar
  17. 17.
    Stocker JT, Madewall JE, Drake RM. Congenital cystic adenomatoid malformation of the lung. Classification and morphologic spectrum. Hum Pathol 1977;8:155–171.PubMedCrossRefGoogle Scholar
  18. 18.
    Stocker JT. Congenital pulmonary airway malformation—a new name for and an expanded classification of congenital cystic adenomatoid malformation of the lung. Histopathology 2002;41(suppl. 2):424–430.Google Scholar
  19. 19.
    Stocker JT, Kagan-Hallet K. Extralobar pulmonary sequestration: analysis of 15 cases. Am J Clin Pathol 1979;72:917–925.PubMedGoogle Scholar
  20. 20.
    Conran RM, Stocker JT. LExtralobar sequestration with frequently associated congenital cystic adenomatoid malformation, type 2: report of 50 cases. Pediatr Dev Pathol 1999;2:454–463.PubMedCrossRefGoogle Scholar
  21. 21.
    Mark EJ. Mesenchymal cystic hamartoma of the lung. N Engl J Med 1986;315:1255–1259.PubMedCrossRefGoogle Scholar

Reference

  1. 1.
    Jing, XY Yokoi T, Nakamura Y, et al. Pulmonary capillary hemangiomatosis. A unique feature of congestive vasculopathy associated with hypertrophic cardiomyopathy. Arch Pathol Lab Med 1998;122:94–96.PubMedGoogle Scholar

References

  1. 1.
    Chow LTC, Shum BSF, Chow WH, Tso CB. Diffuse pulmonary ossification—a rare complication of tuberculosis. Histopathology 1992;20:435–437.PubMedCrossRefGoogle Scholar
  2. 2.
    Fried ED, Godwin TA. Extensive diffuse pulmonary ossification. Chest 1992;102:1614–1615.PubMedGoogle Scholar
  3. 3.
    Jones RW, Roggli VL. Dendriform pulmonary ossification. Report of two cases with unique findings. Am J Clin Pathol 1989;91:398–402.Google Scholar

References

  1. 1.
    Jackson A, Loh C-L. Pulmonary calcification and elastic tissue damage in pseudoxanthoma elasticum. Histopathology 1980;4:607–611.PubMedCrossRefGoogle Scholar
  2. 2.
    Huang S-N, Steele HD, Kuma G, Parker JO. Ultrastructural changes of elastic fibers in pseudoxanthoma elasticum. A study of histogenesis. Arch Pathol 1967;83:108–113.PubMedGoogle Scholar
  3. 3.
    Corrin B, Simpson CGB, Fisher C. Fibrous pseudotumours and cyst formation in the lungs in Ehlers-Danlos syndrome. Histopathology 1990;17:478–479.PubMedCrossRefGoogle Scholar
  4. 4.
    McFarland W, Fuller DE. Mortality in Ehlers-Danlos syndrome due to spontaneous rupture of large arteries. N Engl J Med 1964;271:1309–310.PubMedCrossRefGoogle Scholar
  5. 5.
    Haraguchi S, Fukuda Y. Histogenesis of abnormal elastic fibers in blebs and bullae of patients with spontaneous pneumothorax: ultrastructural and immunohistochemical studies. Acta Pathologica Japonica 1993;43:709–722.PubMedGoogle Scholar
  6. 6.
    Wood JR, Bellamy D, Child AH, Citron KM. Pulmonary disease in patients with Marfan syndrome. Thorax 1984;39:780–784.PubMedGoogle Scholar

Reference

  1. 1.
    Bailey ME, Fraire AE, Greenburg SD, Barnard J, Cagle PT. Pulmonary histopathology in cocaine abusers. Hum Pathol 1994;25:203–207.PubMedCrossRefGoogle Scholar

References

  1. 1.
    Deheinzelin D, Capelozzi VL, Kairalla RA, Barbas Filho JV, Saldiva PH, de Carvalho CR. Interstitial lung disease in primary Sjogren’s syndrome. Clinical-pathological evaluation and response to treatment. Am J Respir Crit Care Med 1996;154:794–799.PubMedGoogle Scholar
  2. 2.
    Constantopoulos SH, Papadimitriou CS, Moutsopoulos HM. Respiratory manifestations in primary Sjogren’s syndrome. A clinical, functional, and histologic study. Chest 1985;88:226–229.PubMedGoogle Scholar
  3. 3.
    Hansen LA, Prakash UB, Colby TV. Pulmonary lymphoma in Sjogren’s syndrome. Mayo Clin Proc 1989;64:920–931.PubMedGoogle Scholar
  4. 4.
    Tsokos M, Lazarou SA, Moutsopoulos HM. Vasculitis in primary Sjogren’s syndrome. Histologic classification and clinical presentation. Am J Clin Pathol 1987;88:26–31.PubMedGoogle Scholar
  5. 5.
    Provost TT, Talal W, Harley JB, Reichlin M, Alexander E. The relationship between anti-Ro (SS-A) antibody-positive Sjogren’s syndrome and anti-Ro (SS-A) antibody-positive lupus erythematosus. Arch Dermatol 1988;124:63–71.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press, Totowa, NJ 2005

Personalised recommendations